Ozempic is a weekly injection containing the active ingredient semaglutide
However, it's worth noting that this study was observational and does not prove cause and effect
Compounding drugs is also allowed when theres a shortage of an FDA-approved drug, which has happened with Wegovy and Ozempic
Semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, reduces appetite and blood sugar levels, making it an effective option for sustainable weight loss
Cumulative evidence shows that GLP-1 exerts direct and beneficial effects on hepatocytes to protect against the progression of NAFL to NASH, suggesting that GLP-1 could be a novel therapy for NASH 14,15,16,17
Use daily, morning and evening, or specifically after aesthetic treatments such as microneedling